Dr. Keiichi Fujiwara is a gynecologic oncologist at the Saitama Medical University International Medical Center. His main interest is multidisciplinary treatment and development of practice changing clinical trials for gynecologic cancer patients. He is a founding member of Gynecologic Oncology Trial and Investigation Consortium (GOTIC), and served as vice president of JGOG from 2012 to 2013. Dr. Fujiwara has been served as a Chair of Gynecologic Cancer Intergroup since 2018, and will be a President-elect of International Gynecologic Cancer Society from October 2020.
Alison Evans has been CEO and Company Secretary for ANZGOG since 2012. In this time ANZGOG has increased its membership from 418 to over 1050 members in Australia and New Zealand. It has also implemented a number of new research programs including its Fund for New Research grants scheme, the OASIS Initiative (a series of signal seeking studies in molecular subtypes of ovarian cancer) and TR-ANZGOG, enabling the collection of gynaecological cancer samples for new and ongoing research.
Alison has led the development and governance of not-for-profit organisations for more than 25 years as both Chief Executive and Company Secretary. She has also been Company Director in a management consulting practise. Her education is in business management, marketing and communications. Prior to her time in not-for-profits Alison worked in Australia and New Zealand in senior roles in media and technology companies.
Alison has led the development and governance of not-for-profit organisations for more than 25 years as both Chief Executive and Company Secretary. She has also been Company Director in a management consulting practise. Her education is in business management, marketing and communications. Prior to her time in not-for-profits Alison worked in Australia and New Zealand in senior roles in media and technology companies.
Dr David Tan is a medical oncologist at the National University Cancer Institute, Singapore and an Associate Professor at the Yong Loo Lin School of Medicine, NUS. His primary clinical and research interests are in gynaecological (ovarian, endometrial and cervical) cancers and the development of novel anti-cancer therapeutic agents (early phase trials). He is the founding President of the Gynecologic Cancer Group Singapore (GCGS), which is a national clinical trials network for gynaecologic cancers in Singapore, and co-chairs the Cervical Cancer Research Network (CCRN) workgroup of the Gynecologic Cancer InterGroup (GCIG). He is currently also the chairman of Asia-Pacific Gynecologic Oncology Trials group (APGOT).
Dr. Byoung-Gie Kim is a gynecologic oncologist, specializing in gynecologic cancer surgery and chemotherapy, at Samsung Medical Center, Sungkyunkwan University in Republic of Korea. His main interest is to construct clinical trials for gynecologic cancer patients. He served as a president of Korean Gynecologic Oncology Group (KGOG) in 2014 and a vice president of Korean Society of Peritoneal Surface Malignancy (KSPSM) in 2016.
Noriko Fujiwara works as a research nurse and a project researcher for the department of palliative medicine and advanced clinical oncology, IMSUT hospital of the Institute of Medical Science, the University of Tokyo, JAPAN. She completed the Project Management Certification Program at UCSD, CA, USA in 2016. She is currently a president of the Japan chapter of the International Association of Clinical Research Nurses (IACRN), a member of the Research Nurse Committee of Gynecologic Oncology Trial and Investigation Consortium (GOTIC), and an operational chair of Asia-Pacific Gynecologic Oncology Trials group (APGOT).
Philip Beale has a special interest in ovarian, breast, colorectal and upper gastrointestinal cancers and is involved in Phase I, II and III clinical trials for all of these cancers and is the PI in several breast and ovarian cancer trials. He has published more than 100 peer reviewed papers. He is the Chair of ANZGOG and is a member of the AGITG and ANZBCTG trials groups. He is recent past Chair of the ANZGOG Ovarian Tumour Working Group, is on the ANZGOG Research Advisory Committee and the Audit Risk and Compliance Committee.
Jae-Weon Kim is a gynecologic oncologist at the Seoul National University. He has been involved at both a national and international level in the field of gynecologic oncology for the last two decades. He has been closely associated with the Gynecologic Cancer InterGroup since 2004. He was Secretary-General/Treasurer during 2009~2015, current Treasurer and President-Elect for the Asian Society of Gynecologic Oncology (ASGO). He is Editor-in-Chief for the 'Journal of Gynecologic Oncology' since 2012, was an editorial board member of the 'Journal of Clinical Oncology' during 2008~2013, and was a senior editor for the 'International Journal of Gynecological Cancer' during 2008~2018. He was one of the initial phase members of the Korean Gynecologic Oncology Group (KGOG). He was elected as a Vice President of the International Gynecologic Cancer Society (from October 2020 for two years).